Proteolysis of insulin-like growth factor-binding protein-3 is increased in urine from patients with diabetic nephropathy

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 3, 2000, Pages 1163-1169

  Shinada, M ^a   Akdeniz, A ^b   Panagiotopoulos, S ^b   Jerums, G ^b   Bach, L A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b AUSTIN HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; INSULIN; SERINE PROTEINASE; SOMATOMEDIN BINDING PROTEIN 3;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DIABETIC NEPHROPATHY; ENZYME ACTIVITY; FEMALE; HUMAN; IMMUNOBLOTTING; IMMUNOREACTIVITY; LIGAND BINDING; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEINURIA; URINALYSIS;

ADULT; BLOTTING, WESTERN; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; HYDROLYSIS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR II; IODINE; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; SERINE ENDOPEPTIDASES;

EID: 0034454630     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.3.1163     Document Type: Article

References (36)

1. Growth factors and the kidney in diabetes mellitus
2. Insulin-like growth factors and their binding proteins: Biological actions
3. Insulin-like growth factor binding proteins
4. High molecular weight insulin-like growth factor binding protein complex
5. Insulin Like growth factor-binding protein proteolysis: An emerging paradigm in insulinike growth factor physiology
6. Increased proteolysis of insulin-like growth factor-binding protein-3 (IGFBP-3) in noninsulin-dependent diabetes mellitus serum, with elevation of a 29-kilodalton (kDa) glycosylated IGFBP-3 fragment contained in the approximately 130- to 150-kDa ternary complex
7. Insulin-like growth factor binding protein-3 proteolysis in children with insulin-dependent diabetes mellitus: A possible role for insulin in the regulation of IGFBP-3 protease activity
8. Focal expression of insulin-like growth factor I in rat kidney collecting duct
9. Localization of mRNAs for insulin-like growth factor binding proteins 1 to 6 in rat kidney
10. The growth hormone insulin-like growth factor axis in kidney revisited
11. Insulin-like growth factors and diabetes
12. Kidney tissue somatomedin C and initial renal growth in diabetic and uninephrectomised rats
13. Effect of puberty on initial kidney growth and rise in kidney IGF-1 in diabetic rats
14. Experimental diabetes increases insuliniike growth factor I and II receptor concentration and gene expression in kidney
15. Focal induction of IGF-I binding proteins in proximal tubules of diabetic rat kidney
16. Transient increase in renal insulin-like growth factor binding proteins during initial kidney hypertrophy in experimental diabetes in rats
17. Expression of insulin-like growth factor binding proteins in the rat kidney: Effects of long-term diabetes
18. Cell-specific regulation of mRNAs for IGF-I and IGF-binding proteins-4 and -5 in streptozotocin-diabetic rat kidney
19. Contribution of growth hormone and IGF-I to early diabetic nephropathy in type 1 diabetes
20. Characterization of urinary insulin-like growth factor binding proteins
21. Urinary insulin-like growth factors (IGF) and IGF-binding proteins in normal subjects, growth hormone deficiency, and renal disease
22. Cyclic AMP agonists increase levels of insulin-like growth factor (IGF) binding protein-6 in PC12 rat pheochromocytoma cells
23. A simple assay for proteolysis of IGFBP-3
24. Semi-quantitative determination of microalbuminuria by urinary dipstick
25. Alteration in insulin-like growth factor-binding proteins (IGFBPs) and IGFBP-3 protease activity in serum and urine from acute and chronic renal failure
26. Characterization of a low molecular mass form of insulin-like growth factor binding protein-3 (17.7 kilodaltons) in urine and serum from healthy children and growth hormone (GH)-deficient patients: Relationship with GH therapy
27. Insulin-like growth factors (IGFs) and IGF binding proteins, serum acid-labile subunit and growth hormone binding protein in nephrotic children
28. Quantification of urinary insulin-like growth factors (IGFs) and IGF binding protein 3 in healthy volunteers' before and after stimulation with recombinant human growth hormone
29. Urinary IGF and IGF binding protein-3 in children with disordered growth
30. Expression of the insulin like growth factor-binding protein 3 (IGFBP-3) gene is increased in human renal carcinomas
31. Protein turnover in the hypertrophying kidney
32. Glomerular metalloproteinase activity in streptozotocin-treated rats and in spontaneously diabetic rats (BB/DP)
33. STZ-induced diabetes results in decreased activity of glomerular cathepsin and metalloproteinease in rats
34. Down-regulation of glomerular matrix metalloproteinase-2 gene in human NIDDM
35. Alterations in renal degradation of albumin in early experimental diabetes in the rat: A new factor in the mechanism of albuminuria
36. Bioactivity of glomerular ultrafiltrate during heavy proteinuria may contribute to renal tubulo-interstitial lesions: Evidence for a role for insulin-like growth factor I